Alzheimer's disease phenotype
Evidence from:
primary |
all sources
Related entities (42)
Mentioned in (47)
Papers in which this entity is mentioned.
- Intranasal Administration of KCNN2 Blocking Peptide Improves Deficits in Cognitive Flexibility in Mouse Model of Fetal Alcohol Spectrum Disorders. (2025)
- Clinical, genomic, and neurophysiological correlates of lifetime suicide attempts among individuals with alcohol dependence. (2024)
- CAGI, the Critical Assessment of Genome Interpretation, establishes progress and prospects for computational genetic variant interpretation methods. (2024)
- Recent advances in polygenic scores: translation, equitability, methods and FAIR tools. (2024)
- Single-cell RNA sequencing of peripheral blood links cell-type-specific regulation of splicing to autoimmune and inflammatory diseases. (2024)
- Human 3D brain organoids: steering the demolecularization of brain and neurological diseases. (2023)
- Pitfalls of predicting age-related traits by polygenic risk scores. (2023)
- Towards understandings of serine/arginine-rich splicing factors. (2023)
- Genetic Influences on the Developing Young Brain and Risk for Neuropsychiatric Disorders. (2023)
- Alternative splicing events as peripheral biomarkers for motor learning deficit caused by adverse prenatal environments. (2023)
- Multi-trait genome-wide association study of opioid addiction: OPRM1 and beyond. (2022)
- Prenatal depression exposure alters white matter integrity and neurodevelopment in early childhood. (2022)
- Large-scale collaboration in ENIGMA-EEG: A perspective on the meta-analytic approach to link neurological and psychiatric liability genes to electrophysiological brain activity. (2021)
- Central white matter integrity alterations in 2-3-year-old children following prenatal alcohol exposure. (2021)
- Prenatal Adversity Alters the Epigenetic Profile of the Prefrontal Cortex: Sexually Dimorphic Effects of Prenatal Alcohol Exposure and Food-Related Stress. (2021)
- Alternative splicing: Human disease and quantitative analysis from high-throughput sequencing. (2021)
- Transcriptomic analyses of gastrulation-stage mouse embryos with differential susceptibility to alcohol. (2021)
- Validity of automated FreeSurfer segmentation compared to manual tracing in detecting prenatal alcohol exposure-related subcortical and corpus callosal alterations in 9- to 11-year-old children. (2020)
- Polygenic risk scores: from research tools to clinical instruments. (2020)
- Emerging Roles of SRSF3 as a Therapeutic Target for Cancer. (2020)
- HSP70 and HSP90 in neurodegenerative diseases. (2020)
- Genome-wide meta-analysis of problematic alcohol use in 435,563 individuals yields insights into biology and relationships with other traits. (2020)
- Ethanol activates immune response in lymphoblastoid cells. (2019)
- Genome-wide association studies of alcohol dependence, DSM-IV criterion count and individual criteria. (2019)
- PASSPORT-seq: A Novel High-Throughput Bioassay to Functionally Test Polymorphisms in Micro-RNA Target Sites. (2018)
- Gene-environment interactions in development and disease. (2017)
- Longitudinal changes in pubertal maturation and white matter microstructure. (2017)
- Genome-wide Association Study of Cannabis Dependence Severity, Novel Risk Variants, and Shared Genetic Risks. (2016)
- Detecting Genomic Signatures of Natural Selection with Principal Component Analysis: Application to the 1000 Genomes Data. (2016)
- Genomewide Association Study for Maximum Number of Alcoholic Drinks in European Americans and African Americans. (2015)
- Peroxisome proliferator-activated receptors α and γ are linked with alcohol consumption in mice and withdrawal and dependence in humans. (2015)
- Genome-wide association study of cocaine dependence and related traits: FAM53B identified as a risk gene. (2014)
- Prenatal alcohol exposure reduces magnetic susceptibility contrast and anisotropy in the white matter of mouse brains. (2014)
- Using genetic information from candidate gene and genome-wide association studies in risk prediction for alcohol dependence. (2014)
- Common biological networks underlie genetic risk for alcoholism in African- and European-American populations. (2013)
- A genome-wide association study of alcohol-dependence symptom counts in extended pedigrees identifies C15orf53. (2013)
- Dosage transmission disequilibrium test (dTDT) for linkage and association detection. (2013)
- Amyloid pathway-based candidate gene analysis of [(11)C]PiB-PET in the Alzheimer's Disease Neuroimaging Initiative (ADNI) cohort. (2012)
- Myeloid cells in tumor inflammation. (2012)
- White matter microstructural alterations in children with prenatal methamphetamine/polydrug exposure. (2012)
- Divergent roles of ALS-linked proteins FUS/TLS and TDP-43 intersect in processing long pre-mRNAs. (2012)
- The effects of a single memantine treatment on behavioral alterations associated with binge alcohol exposure in neonatal rats. (2011)
- Integrative analysis of the melanoma transcriptome. (2010)
- Evidence for genes on chromosome 2 contributing to alcohol dependence with conduct disorder and suicide attempts. (2010)
- Differentiating prenatal exposure to methamphetamine and alcohol versus alcohol and not methamphetamine using tensor-based brain morphometry and discriminant analysis. (2010)
- 3' end mRNA processing: molecular mechanisms and implications for health and disease. (2008)
- Alcoholism and human electrophysiology. (2003)
Merged raw entities (21)
All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.
| Raw name | Type | Papers | Mentions |
|---|---|---|---|
| alzheimer's disease | phenotype | 236 | 1093 |
| ad | phenotype | 101 | 365 |
| alzheimer disease | phenotype | 57 | 96 |
| ad | cohort | 12 | 41 |
| sporadic alzheimer's disease | phenotype | 8 | 11 |
| familial alzheimer's disease | phenotype | 7 | 14 |
| familial ad | phenotype | 4 | 5 |
| sporadic ad | phenotype | 4 | 4 |
| alzheimer's | phenotype | 2 | 2 |
| ad group | phenotype | 1 | 1 |
| lifetime ad | phenotype | 1 | 1 |
| ad patients | phenotype | — | — |
| ad phenotypes | phenotype | — | — |
| ad samples | phenotype | — | — |
| alzheimer’s cases | phenotype | — | — |
| alzheimer×s disease | phenotype | — | — |
| alzheimer's disease samples | phenotype | — | — |
| alzheimer's patients | phenotype | — | — |
| alzheimer’s patients | phenotype | — | — |
| alzheimer’s-type disease | phenotype | — | — |
| lifetime ad only | phenotype | — | — |